Cargando…

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

Statins, a family of FDA-approved cholesterol-lowering drugs that inhibit the rate-limiting enzyme of the mevalonate metabolic pathway, have demonstrated anticancer activity. Evidence shows that dipyridamole potentiates statin-induced cancer cell death by blocking a restorative feedback loop trigger...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Leeuwen, Jenna E., Ba-Alawi, Wail, Branchard, Emily, Cruickshank, Jennifer, Schormann, Wiebke, Longo, Joseph, Silvester, Jennifer, Gross, Peter L., Andrews, David W., Cescon, David W., Haibe-Kains, Benjamin, Penn, Linda Z., Gendoo, Deena M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592602/ https://www.ncbi.nlm.nih.gov/pubmed/36280687 http://dx.doi.org/10.1038/s41467-022-33144-9

Ejemplares similares

Creating reproducible pharmacogenomic analysis pipelines
por: Mammoliti, Anthony, et al.
Publicado: (2019)

MM2S: personalized diagnosis of medulloblastoma patients and model systems
por: Gendoo, Deena M.A., et al.
Publicado: (2016)

The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
por: Longo, Joseph, et al.
Publicado: (2020)

The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor–resistant ER(+) breast cancer with mitotic aberrations
por: Soria-Bretones, Isabel, et al.
Publicado: (2022)

Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids
por: Prince, Elisabeth, et al.
Publicado: (2022)

DNA replication stress: a source of APOBEC3B expression in breast cancer
por: Cescon, David W., et al.
Publicado: (2016)

Gene Expression Analyses in Breast Cancer: Sample Matters
por: Haibe-Kains, Benjamin, et al.
Publicado: (2018)

Gene isoforms as expression-based biomarkers predictive of drug response in vitro
por: Safikhani, Zhaleh, et al.
Publicado: (2017)

Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro
por: Safikhani, Zhaleh, et al.
Publicado: (2018)

Assessment of pharmacogenomic agreement
por: Safikhani, Zhaleh, et al.
Publicado: (2016)

MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature
por: Gendoo, Deena M. A., et al.
Publicado: (2019)

A reference library for assigning protein subcellular localizations by image-based machine learning
por: Schormann, Wiebke, et al.
Publicado: (2020)

PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies
por: Smirnov, Petr, et al.
Publicado: (2018)

SYNERGxDB: an integrative pharmacogenomic portal to identify synergistic drug combinations for precision oncology
por: Seo, Heewon, et al.
Publicado: (2020)

Revisiting inconsistency in large pharmacogenomic studies
por: Safikhani, Zhaleh, et al.
Publicado: (2017)

The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism
por: Elliott, Mitchell J., et al.
Publicado: (2018)

Evaluation of statistical approaches for association testing in noisy drug screening data
por: Smirnov, Petr, et al.
Publicado: (2022)

Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016)

Pharmacogenomic insights into treatment and management of statin-induced myopathy
por: Peters, Bas JM, et al.
Publicado: (2009)

Genome-wide analysis of Homo sapiens, Arabidopsis thaliana, and Saccharomyces cerevisiae reveals novel attributes of tail-anchored membrane proteins
por: Brito, Glauber Costa, et al.
Publicado: (2019)

Bioinformatics and computational approaches for analyzing patient-derived disease models in cancer research
por: Gendoo, Deena M.A.
Publicado: (2020)

Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing
por: Canestaro, William J., et al.
Publicado: (2012)

PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis
por: Feizi, Nikta, et al.
Publicado: (2021)

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
por: Wu, Qin, et al.
Publicado: (2020)

Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial
por: Murphy, William A., et al.
Publicado: (2022)

PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
por: Wu, Qin, et al.
Publicado: (2022)

Public data and open source tools for multi-assay genomic investigation of disease
por: Kannan, Lavanya, et al.
Publicado: (2016)

Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review
por: Yow, Hui-Yin, et al.
Publicado: (2023)

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
por: Turner, Richard Myles, et al.
Publicado: (2019)

Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin
por: Mitchell, Dominic, et al.
Publicado: (2016)

Origins and Evolution of the HET-s Prion-Forming Protein: Searching for Other Amyloid-Forming Solenoids
por: Gendoo, Deena M. A., et al.
Publicado: (2011)

The Landscape of the Prion Protein's Structural Response to Mutation Revealed by Principal Component Analysis of Multiple NMR Ensembles
por: Gendoo, Deena M. A., et al.
Publicado: (2012)

Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing
por: Floyd, James S., et al.
Publicado: (2019)

Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer
por: Parsyan, Armen, et al.
Publicado: (2021)

Quantitative assessment and validation of network inference methods in bioinformatics
por: Haibe-Kains, Benjamin, et al.
Publicado: (2014)

An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer
por: Longo, Joseph, et al.
Publicado: (2019)

Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer
por: Bailey, Swneke D., et al.
Publicado: (2016)

Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy
por: Chung, Philip E. D., et al.
Publicado: (2020)

Assessment of modelling strategies for drug response prediction in cell lines and xenografts
por: Kurilov, Roman, et al.
Publicado: (2020)

The carboxyl-terminal sequence of PUMA binds to both anti-apoptotic proteins and membranes
por: Pemberton, James M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2dgi439nnvodqac6c8el6c318h